Literature DB >> 4549497

Factors influencing the level of dapsone in blood.

B Beiguelman, W Pinto, M M El-Guindy, H Krieger.   

Abstract

The level of dapsone in the blood 4 and 6 h after the ingestion of the 7th daily dose of 100 mg of the drug was investigated in 36 adult males with leprosy who had normal renal function and were free of diarrhoea and emesis. The bimodal distribution of the dapsone levels at 6 h was shown by multiple regression analysis to be due to a negative correlation between this trait and the haematocrit value. Among the patients with high dapsone blood levels, 81.8% presented haematocrit values under 36%, whereas only 20% of those with low levels showed low haematocrit values. Partial regression coefficients, calculated for the dapsone level on the age, weight of the patient, estimated number of years since the onset of leprosy, number of years under sulfone treatment, and blood levels of haemoglobin, albumin, and globulins, did not show statistical significance.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4549497      PMCID: PMC2366315     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  The treatment of lepromatous leprosy with 4:4'-diaminodiphenyl sulfone in oil; findings in 100 cases treated for one year.

Authors:  B D MOLESWORTH; P S NARAYANASWAMI
Journal:  Int J Lepr       Date:  1949 Jul-Sep

2.  Dapsone acetylation and the treatment of leprosy.

Authors:  G A Ellard; P T Gammon; H S Helmy; R J Rees
Journal:  Nature       Date:  1972-09-15       Impact factor: 49.962

3.  Metabolic disposition of dapsone in patients with dapsone-resistant leprosy.

Authors:  J H Peters; G R Gordon; L Levy; M A Strokan; R R Jacobson; C D Enna; W F Kirchheimer
Journal:  Am J Trop Med Hyg       Date:  1974-03       Impact factor: 2.345

4.  The polymorphic acetylation of dapsone in man.

Authors:  R Gelber; J H Peters; G R Gordon; A J Glazko; L Levy
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.